Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan
Authors
Keywords
Risk, Resistance, Stenotrophomonas maltophilia,, levofloxacin, Trimethoprim/sulfamethoxazole
Journal
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-15
DOI
10.1016/j.jmii.2020.12.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
- (2019) Ana C Gales et al. Open Forum Infectious Diseases
- Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
- (2019) Chih-Cheng Lai et al. Infection and Drug Resistance
- Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia
- (2019) Paula Blanco et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients
- (2019) Ching Hsun Wang et al. JOURNAL OF HOSPITAL INFECTION
- Overexpression of the Efflux Pumps SmeVWX and SmeDEF Is a Major Cause of Resistance to Co-trimoxazole in Stenotrophomonas maltophilia
- (2018) María Blanca Sánchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors and molecular mechanisms associated with trimethoprim–sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico
- (2017) Sandra Abril Herrera-Heredia et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Risk factors for hospital acquisition of trimethoprim–sulfamethoxazole resistant Stenotrophomonas maltophilia in adults: A matched case-control study
- (2017) Ching-Hsun Wang et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India
- (2016) Gajanand Mittal et al. BMC MICROBIOLOGY
- Whole-Genome Sequencing Identifies Emergence of a Quinolone Resistance Mutation in a Case of Stenotrophomonas maltophilia Bacteremia
- (2015) Theodore R. Pak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for levofloxacin resistance in Stenotrophomonas maltophilia from respiratory tract in a regional hospital
- (2015) Chien-Jung Pien et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options
- (2015) Ya-Ting Chang et al. Frontiers in Microbiology
- Monotherapy with Fluoroquinolone or Trimethoprim-Sulfamethoxazole for Treatment of Stenotrophomonas maltophilia Infections
- (2013) Yu Lin Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Can Levofloxacin Be a Useful Alternative to Trimethoprim-Sulfamethoxazole for Treating Stenotrophomonas maltophilia Bacteremia?
- (2013) Sun Young Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New strategies againstStenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen
- (2013) Joanna S Brooke Expert Review of Anti-Infective Therapy
- Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study
- (2013) G. G. Zhanel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Korea, and the Activity of Antimicrobial Combinations against the Isolates
- (2013) Hae-Sun Chung et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Stenotrophomonas maltophilia in Malaysia: molecular epidemiology and trimethoprim–sulfamethoxazole resistance
- (2012) Vasanthakumari Neela et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Tigecycline as a therapeutic option inStenotrophomonas maltophiliainfections
- (2012) Yasemin Tezer Tekçe et al. JOURNAL OF CHEMOTHERAPY
- A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan
- (2011) Hsiu Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Antimicrobial Susceptibilities of a Worldwide Collection of Stenotrophomonas maltophilia Isolates Tested against Tigecycline and Agents Commonly Used for S. maltophilia Infections
- (2010) D. J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Risk Factors for Multi-Drug Resistant Organisms to Guide Empiric Antibiotic Selection in Long Term Care: A Dilemma
- (2010) Paul Drinka et al. Journal of the American Medical Directors Association
- Case–Control Studies Reporting on Risk Factors for Emergence of Antimicrobial Resistance: Bias Associated with the Selection of the Control Group
- (2010) Petros I. Rafailidis et al. Microbial Drug Resistance
- Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia
- (2009) Veronica Brito et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Stenotrophomonas maltophilia: an emerging opportunist human pathogen
- (2009) W John Looney et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now